Artemisinin relieves myocardial ischemia-reperfusion injury via modulating miR-29b-3p and hemicentin 1 (vol 13, 918966, 2022)

被引：0
|
作者：
Han, Junyu [1 ]
Zhang, Ziguan [1 ]
Zhang, Zhonghe [1 ]
Yang, Shuyu [2 ]
机构：
[1] Xiamen Univ, Affiliated Hosp 1, Sch Med, Dept Cardiol, Xiamen, Fujian, Peoples R China
[2] Xiamen Univ, Affiliated Hosp 1, Xiamen Diabet Inst, Sch Med, Xiamen, Fujian, Peoples R China
来源：
FRONTIERS IN PHARMACOLOGY | 2023年 / 14卷
关键词：
myocardial ischemia-reperfusion; artemisinin; high throughput sequencing; miR-29b-3p; hemicentin; 1; oxidative stress;
D O I：
10.3389/fphar.2023.1169734
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Upregulation of miR-29b-3p alleviates coronary microembolization-induced myocardial injury via regulating BMF and GSK-3β
    Zhenbai Qin
    Xiantao Wang
    You Zhou
    Jing Zheng
    Hongqing Li
    Lang Li
    Apoptosis, 2023, 28 : 210 - 221
  • [12] Upregulation of miR-29b-3p alleviates coronary microembolization-induced myocardial injury via regulating BMF and GSK-3β
    Qin, Zhenbai
    Wang, Xiantao
    Zhou, You
    Zheng, Jing
    Li, Hongqing
    Li, Lang
    APOPTOSIS, 2023, 28 (1-2) : 210 - 221
  • [13] Inhibition of circ_0073932 attenuates myocardial ischemia-reperfusion injury via miR-493-3p/FAF1/JNK
    Su, Yang
    Zhao, Lili
    Lei, Dongli
    Yang, Xiaoming
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2024, 60 (06) : 628 - 643
  • [14] Inhibition of circ_0073932 attenuates myocardial ischemia-reperfusion injury via miR-493-3p/FAF1/JNK
    Su, Yang
    Zhao, Lili
    Lei, Dongli
    Yang, Xiaoming
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2024, 60 (06) : 628 - 643
  • [15] AMPK activation alleviates myocardial ischemia-reperfusion injury by regulating Drp1-mediated mitochondrial dynamics (vol 13, 862204, 2022)
    Du, Jingxia
    Li, Hongchao
    Song, Jingjing
    Wang, Tingting
    Dong, Yibo
    Zhan, An
    Li, Yan
    Liang, Gaofeng
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [16] miR-190-5p Alleviates Myocardial Ischemia-Reperfusion Injury by Targeting PHLPP1
    Li, Yangxue
    Li, Zhibo
    Liu, Jiangen
    Liu, Yihang
    Miao, Guobin
    DISEASE MARKERS, 2021, 2021
  • [17] Visfatin relieves myocardial ischemia-reperfusion injury through activation of P13K/Akt/HSP70 signaling axis
    Xin, B-R
    Li, P.
    Liu, X-L
    Zhang, X-F
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (20) : 10779 - 10789
  • [18] LncRNA TUG1 contributes to cardiac hypertrophy via regulating miR-29b-3p
    Zou, Xue
    Wang, Jialiang
    Tang, Li
    Wen, Qian
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2019, 55 (07) : 482 - 490
  • [19] LncRNA TUG1 contributes to cardiac hypertrophy via regulating miR-29b-3p
    Xue Zou
    Jialiang Wang
    Li Tang
    Qian Wen
    In Vitro Cellular & Developmental Biology - Animal, 2019, 55 : 482 - 490
  • [20] MiR-506 alleviates myocardial ischemia-reperfusion injury via targeting PI3K/AKT
    Zhang, M.
    Wang, J-Y
    Li, L.
    Li, G-M
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (24) : 12896 - 12903
12345